Q1 2024 · 13F-HR
Affinity Asset Advisors, LLCholdings as filed
Filed 2024-05-14 · accession 0001999371-24-006067
$807.8M
Reported value
95
Positions
2024-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 78464A870 | XBI | SPDR SER TR | $66.4M | 8.22% | 700,000 | PUT | SOLE |
| 60770K107 | MRNA | MODERNA INC | $42.6M | 5.28% | 400,000 | PUT | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $39.3M | 4.87% | 592,093 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $36.0M | 4.46% | 837,387 | Common | SOLE |
| 558868105 | MDGL | MADRIGAL PHARMACEUTICALS INC | $30.7M | 3.80% | 115,000 | Common | SOLE |
| 881624209 | TEVA | TEVA PHARMACEUTICAL INDS LTD | $23.4M | 2.89% | 1,655,000 | CALL | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS IN | $22.0M | 2.72% | 470,000 | Common | SOLE |
| 05280R100 | AUTL | AUTOLUS THERAPEUTICS PLC | $21.5M | 2.67% | 3,375,000 | Common | SOLE |
| 15117B202 | CLDX | CELLDEX THERAPEUTICS INC NEW | $21.4M | 2.65% | 510,000 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $20.9M | 2.58% | 300,000 | Common | SOLE |
| 92337R101 | VERA | VERA THERAPEUTICS INC | $20.3M | 2.51% | 470,000 | Common | SOLE |
| 45790W108 | — | INOZYME PHARMA INC | $20.2M | 2.51% | 2,642,519 | Common | SOLE |
| 881624209 | TEVA | TEVA PHARMACEUTICAL INDS LTD | $19.8M | 2.45% | 1,400,000 | Common | SOLE |
| 10806XAB8 | BBIO 2.5 03/15/27 | BRIDGEBIO PHARMA INC | $18.3M | 2.27% | 17,000,000 | Common | SOLE |
| 50127T109 | KURA | KURA ONCOLOGY INC | $15.6M | 1.93% | 730,492 | Common | SOLE |
| 00773J202 | SYRE | SPYRE THERAPEUTICS INC | $15.6M | 1.93% | 410,000 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $13.2M | 1.63% | 817,833 | Common | SOLE |
| 07725L102 | ONC | BEIGENE LTD | $12.8M | 1.59% | 82,143 | Common | SOLE |
| 15678U128 | CERE1EUR | CEREVEL THERAPEUTICS HLDNG I | $12.7M | 1.57% | 300,000 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $11.9M | 1.47% | 810,253 | Common | SOLE |
| 04635X102 | CATBUSD | ASTRIA THERAPEUTICS INC | $11.9M | 1.47% | 845,606 | Common | SOLE |
| 670703107 | NUVL | NUVALENT INC | $11.3M | 1.39% | 150,000 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $11.2M | 1.38% | 139,758 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $9.7M | 1.20% | 165,000 | Common | SOLE |
| 02043QAB3 | ALNY 1 09/15/27 | ALNYLAM PHARMACEUTICALS INC | $9.4M | 1.17% | 10,000,000 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS PLC | $9.4M | 1.16% | 830,546 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $9.2M | 1.14% | 285,000 | Common | SOLE |
| 46333X108 | IRWD | IRONWOOD PHARMACEUTICALS INC | $9.0M | 1.11% | 1,029,500 | CALL | SOLE |
| 20451W101 | CMPS | COMPASS PATHWAYS PLC | $8.6M | 1.06% | 1,027,868 | Common | SOLE |
| 45332Y109 | NARIUSD | INARI MED INC | $8.4M | 1.04% | 175,000 | Common | SOLE |
| G31249108 | ESTA | ESTABLISHMENT LABS HLDGS INC | $8.4M | 1.04% | 164,589 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $8.3M | 1.02% | 2,500,000 | Common | SOLE |
| 61775R105 | MORFUSD | MORPHIC HLDG INC | $7.9M | 0.98% | 225,000 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $7.7M | 0.96% | 250,000 | CALL | SOLE |
| 682143AG7 | OMER 5.25 02/15/26 | OMEROS CORP | $7.6M | 0.94% | 10,500,000 | Common | SOLE |
| N62509109 | NAMS | NEWAMSTERDAM PHARMA COMPANY | $6.8M | 0.84% | 286,200 | Common | SOLE |
| 28623U101 | — | ELEVATION ONCOLOGY INC | $6.5M | 0.81% | 1,268,825 | Common | SOLE |
| 39868T105 | 2JQ | GRITSTONE BIO INC | $6.1M | 0.76% | 2,390,600 | PUT | SOLE |
| 46489V104 | ISREUR | PERSPECTIVE THERAPEUTICS INC | $6.1M | 0.75% | 5,100,000 | Common | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $6.0M | 0.74% | 40,000 | CALL | SOLE |
| 00091E109 | ABSI | ABSCI CORPORATION | $5.8M | 0.72% | 1,025,000 | Common | SOLE |
| 19249HAB9 | — | COHERUS BIOSCIENCES INC | $5.8M | 0.72% | 9,000,000 | Common | SOLE |
| 805111101 | SVRA | SAVARA INC | $5.7M | 0.71% | 1,150,000 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $5.6M | 0.69% | 80,000 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $5.5M | 0.68% | 80,000 | Common | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $5.3M | 0.65% | 500,000 | Common | SOLE |
| 359616109 | FULC | FULCRUM THERAPEUTICS INC | $5.2M | 0.64% | 550,339 | Common | SOLE |
| 75382E109 | — | RAPT THERAPEUTICS INC | $5.2M | 0.64% | 577,100 | PUT | SOLE |
| 40131M109 | GH | GUARDANT HEALTH INC | $5.2M | 0.64% | 250,000 | CALL | SOLE |
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEUTICS INC | $4.9M | 0.61% | 100,000 | Common | SOLE |
| 501147102 | KRYS | KRYSTAL BIOTECH INC | $4.8M | 0.59% | 26,746 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $4.7M | 0.58% | 144,400 | CALL | SOLE |
| 59045L106 | — | MERSANA THERAPEUTICS INC | $4.5M | 0.55% | 1,000,000 | Common | SOLE |
| H17182108 | CRSP | CRISPR THERAPEUTICS AG | $4.4M | 0.55% | 65,000 | CALL | SOLE |
| 230031106 | CGEM | CULLINAN ONCOLOGY INC | $4.4M | 0.55% | 258,588 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $4.2M | 0.52% | 327,959 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $4.1M | 0.51% | 50,000 | Common | SOLE |
| 76200L309 | RZLT | REZOLUTE INC | $4.1M | 0.51% | 1,600,000 | Common | SOLE |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $4.0M | 0.50% | 160,000 | Common | SOLE |
| 61559X104 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $3.8M | 0.47% | 75,000 | Common | SOLE |
| N44445109 | IMTX | IMMATICS N.V | $3.7M | 0.46% | 350,000 | Common | SOLE |
| 46116X101 | ITCIEUR | INTRA-CELLULAR THERAPIES INC | $3.5M | 0.43% | 50,000 | Common | SOLE |
| 04280A100 | ARWR | ARROWHEAD PHARMACEUTICALS IN | $3.4M | 0.42% | 120,000 | Common | SOLE |
| 45256X103 | IBRX | IMMUNITYBIO INC | $3.2M | 0.39% | 589,400 | PUT | SOLE |
| 65343E108 | NXTCEUR | NEXTCURE INC | $3.0M | 0.38% | 1,359,037 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $3.0M | 0.37% | 450,000 | Common | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $2.9M | 0.36% | 100,000 | Common | SOLE |
| 359616109 | FULC | FULCRUM THERAPEUTICS INC | $2.6M | 0.32% | 275,000 | CALL | SOLE |
| G4444H101 | BBOT | HELIX ACQUISITION CORP II | $2.6M | 0.32% | 250,000 | Common | SOLE |
| G31249108 | ESTA | ESTABLISHMENT LABS HLDGS INC | $2.5M | 0.32% | 50,000 | CALL | SOLE |
| 75901B107 | RGNX | REGENXBIO INC | $2.3M | 0.29% | 110,000 | Common | SOLE |
| N62509117 | NAMSW | NEWAMSTERDAM PHARMA COMPANY | $2.2M | 0.28% | 202,599 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $2.0M | 0.25% | 75,000 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $1.9M | 0.23% | 75,000 | CALL | SOLE |
| Y95308105 | WVE | WAVE LIFE SCIENCES LTD | $1.8M | 0.22% | 286,585 | Common | SOLE |
| 101137107 | BSX | BOSTON SCIENTIFIC CORP | $1.7M | 0.21% | 25,000 | Common | SOLE |
| 49372L100 | — | KEZAR LIFE SCIENCES INC | $1.6M | 0.20% | 1,761,778 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $1.5M | 0.19% | 50,000 | Common | SOLE |
| G31659108 | — | ARYA SCIENCES ACQU CORP IV | $1.5M | 0.19% | 133,500 | Common | SOLE |
| 87583X109 | TNGX | TANGO THERAPEUTICS INC | $1.2M | 0.15% | 150,274 | Common | SOLE |
| G9TY5A101 | ZURA | ZURA BIO LTD | $1.2M | 0.14% | 450,009 | Common | SOLE |
| 89157D105 | TRML | TOURMALINE BIO INC | $1.1M | 0.14% | 50,000 | Common | SOLE |
| 89422G107 | TVTX | TRAVERE THERAPEUTICS INC | $963,750 | 0.12% | 125,000 | Common | SOLE |
| 05455M100 | — | AVROBIO INC | $896,000 | 0.11% | 700,000 | Common | SOLE |
| 03615A108 | ANVS | ANNOVIS BIO INC | $867,510 | 0.11% | 72,900 | PUT | SOLE |
| 75382E109 | — | RAPT THERAPEUTICS INC | $538,800 | 0.07% | 60,000 | CALL | SOLE |
| 74346M406 | PMNEUR | PROMIS NEUROSCIENCES INC | $507,980 | 0.06% | 265,958 | Common | SOLE |
| N44445117 | IMTXW | IMMATICS N.V | $486,730 | 0.06% | 187,204 | Common | SOLE |
| 746964105 | QTTB | Q32 BIO INC | $473,320 | 0.06% | 27,777 | Common | SOLE |
| 21077P108 | CNTX | CONTEXT THERAPEUTICS INC | $453,767 | 0.06% | 328,817 | Common | SOLE |
| 38000Q102 | GLYCEUR | GLYCOMIMETICS INC | $426,900 | 0.05% | 142,300 | PUT | SOLE |
| 702712100 | — | PASSAGE BIO INC | $356,759 | 0.04% | 264,266 | Common | SOLE |
| 05338F306 | AVTX | AVALO THERAPEUTICS INC | $217,500 | 0.03% | 10,000 | Common | SOLE |
| 14817C115 | — | CASSAVA SCIENCES INC | $97,524 | 0.01% | 24,200 | Common | SOLE |
| 77313F114 | RCKTW | ROCKET PHARMACEUTICALS INC | $22,440 | 0.00% | 75,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.